Inmune Bio, Inc. (INMB)

CIK 1711754 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Inmune Bio, Inc..

Recent SEC filings

FiledFormAccession number
Nov 5, 202610-Q0001213900-26-116359
Oct 29, 20268-K0001213900-26-113535
Oct 29, 2026424B50001213900-26-113531
Oct 21, 20268-K0001213900-26-111207
Sep 23, 202630001213900-26-102340
Sep 23, 202640001213900-26-102342
Sep 17, 202640001213900-26-100877
Sep 16, 202630001213900-26-100650
Sep 14, 20268-K0001213900-26-099700
Aug 6, 202610-Q0001213900-26-086135
Jul 31, 20268-K0001213900-26-083961
Jul 7, 202640001213900-26-075736
Jul 7, 202640001213900-26-075737
Jul 7, 202640001213900-26-075738
Jul 1, 20268-K0001213900-26-073983
Jun 23, 20268-K0001213900-26-071082
Jun 17, 20268-K0001213900-26-069611
Jun 2, 20268-K0001213900-26-064144
May 14, 20268-K0001213900-26-056599
May 7, 202610-Q0001213900-26-053338
May 5, 20268-K0001213900-26-052231
Apr 23, 2026DEF 14A0001213900-26-047080
Mar 30, 202610-K0001213900-26-036370
Feb 27, 20268-K0001213900-26-021120
Feb 23, 20268-K0001213900-26-019321